Children's health and the environment: a new agenda for prevention research

Environmental Health Perspectives
Philip J LandriganW A Suk

Abstract

Patterns of illness in American children have changed dramatically in this century. The ancient infectious diseases have largely been controlled. The major diseases confronting children now are chronic and disabling conditions termed the "new pediatric morbidity"--asthma mortality has doubled; leukemia and brain cancer have increased in incidence; neurodevelopmental dysfunction is widespread; hypospadias incidence has doubled. Chemical toxicants in the environment as well as poverty, racism, and inequitable access to medical care are factors known and suspected to contribute to causation of these pediatric diseases. Children are at risk of exposure to over 15,000 high-production-volume synthetic chemicals, nearly all of them developed in the past 50 years. These chemicals are used widely in consumer products and are dispersed in the environment. More than half are untested for toxicity. Children appear uniquely vulnerable to chemical toxicants because of their disproportionately heavy exposures and their inherent biological susceptibility. To prevent disease of environmental origin in America's children, the Children's Environmental Health Network (CEHN) calls for a comprehensive, national, child-centered agenda. This agenda mu...Continue Reading

References

Mar 29, 1979·The New England Journal of Medicine·H L NeedlemanP Barrett
May 1, 1976·American Journal of Epidemiology·M B MeyerJ A Tonascia
Jul 1, 1992·American Journal of Public Health·P J Landrigan
Jan 11, 1990·The New England Journal of Medicine·H L NeedlemanE N Allred
Aug 25, 1988·The New England Journal of Medicine·A J McMichaelR J Roberts
Apr 23, 1987·The New England Journal of Medicine·D BellingerM Rabinowitz
May 24, 1985·JAMA : the Journal of the American Medical Association·D D Baird, A J Wilcox
Feb 1, 1995·Journal of the National Cancer Institute·S S DevesaJ F Fraumeni
Mar 8, 1995·JAMA : the Journal of the American Medical Association·H S Klonoff-CohenK J Wiley
Jun 1, 1994·Environmental Health Perspectives·M Schaefer
Jul 1, 1994·Environmental Research·J Schwartz
Jan 1, 1994·Annual Review of Public Health·D W Dockery, C A Pope
Sep 1, 1993·Toxicology and Industrial Health·R D Bullard, B H Wright
Sep 1, 1995·Environmental Health Perspectives·C F Bearer
Apr 17, 1996·Journal of the National Cancer Institute·F P Perera
Sep 12, 1996·The New England Journal of Medicine·J L Jacobson, S W Jacobson
Jan 1, 1997·Journal of the National Cancer Institute·A EkbomD Trichopoulos
Jan 1, 1997·Paediatric and Perinatal Epidemiology·J Golding
Feb 1, 1997·Environmental Health Perspectives·C BearerC Shackleton
Jan 1, 1997·Annual Review of Public Health·P Lee, D Paxman
May 29, 1997·The New England Journal of Medicine·J C Bailar, H L Gornik
Nov 14, 1997·Pediatrics·L J PaulozziR J Jackson

❮ Previous
Next ❯

Citations

May 26, 1999·Environmental Health Perspectives·P J LandriganR W Amler
Sep 3, 2002·Environmental Health Perspectives·Anthony KnapUmit Unluata
Aug 5, 2003·Environmental Health Perspectives·William A SukB S Zheng
May 24, 2005·Archives of Disease in Childhood·B P Lanphear, C F Bearer
Apr 4, 2006·Environmental Health Perspectives·Amy Pelka MuchaNatalia Chislovska
Oct 13, 2006·Environmental Health Perspectives·Bruce P LanphearSandra Beirne
Feb 16, 2010·International Journal of Health Geographics·Kate HoffmanVerónica M Vieira
Jun 10, 2011·International Journal of Environmental Research and Public Health·Peter P EgeghyLinda S Sheldon
Dec 4, 2003·Mutation Research·William A SukMaureen D Avakian
Sep 10, 2002·Journal of Toxicology. Clinical Toxicology·Jenny Pronczuk de Garbino
May 7, 2005·International Journal of Occupational and Environmental Health·Nicolas A Van LarebekeKirsi Vähäkangas
Jun 15, 2016·Journal of Toxicology and Environmental Health. Part a·Santokh GillWayne Bowers
Jan 18, 2011·Allergologia et immunopathologia·C H RaziR Renda
Aug 30, 2016·International Journal of Environmental Research and Public Health·Samantha Teixeira, Anita Zuberi
Sep 23, 2008·International Journal of Hygiene and Environmental Health·Sherif O SherifMosaad A Abdel-Wahhab
Aug 2, 2011·Environmental Research·Suh-Woan HuChang-Chuan Chan
Nov 17, 2017·International Journal of Environmental Research and Public Health·Perry E SheffieldMaida P Galvez
Jan 31, 2006·Policy, Politics & Nursing Practice·Ruth E Malone
May 28, 2003·American Journal of Industrial Medicine·C Aguilar-GarduñoM Hernandez-Avila
Aug 14, 2015·Risk Analysis : an Official Publication of the Society for Risk Analysis·Susan Mello, Robert C Hornik
Dec 23, 2021·American Journal of Public Health·Marianne SullivanChris Sellers

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.